TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

Zepbound Just Got Cheaper: Lilly Cuts Prices On LillyDirect To Broaden Access

Benzinga Logo Benzinga By Vandana Singh
Zepbound Just Got Cheaper: Lilly Cuts Prices On LillyDirect To Broaden Access

Eli Lilly reduced prices for Zepbound single-dose vials on its digital healthcare platform, offering patients lower monthly costs for weight loss medication, ranging from $299 to $449 per month through its Self Pay Journey Program.

Insights
GSpC   positive

Expected recovery in dealmaking, global M&A activity increasing, valued at 14x 2026 earnings projections, and potential for growth in financial services


LLY   positive

Company proactively lowered medication prices to improve patient access and affordability, demonstrating commitment to healthcare accessibility